Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27558458 | 0.98 | LMNA (0.31) | LMNA | |
| Methyl Alcohol SCHEMBL20552308 | 0.96 | LMNA (0.33) | LMNAPOLB | |
| SCHEMBL377437 | 0.91 | TPMT (0.33) | LMNA | |
| SCHEMBL4833943 | 0.91 | POLB (0.35) | LMNAPOLB | |
| SCHEMBL9787543 | 0.91 | LMNA (0.35) | LMNAPOLB | |
| SCHEMBL9787544 | 0.91 | LMNA (0.35) | LMNAPOLB | |
| Hydrochloric Acid SCHEMBL28391599 | 0.88 | KDM4E (0.32) | LMNA | |
| SCHEMBL6397169 | 0.88 | KDM4E (0.32) | LMNA | |
| Hydrochloric Acid SCHEMBL620189 | 0.88 | KDM4E (0.32) | LMNA | |
| Hydrochloric Acid SCHEMBL9787533 | 0.88 | LMNA (0.34) | LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8445725-B2 | Process for the preparation of iosimenol | MALLINCKRODT LLC (US) | 2013-05-21 | — | — | US | claimed |
| EP-2240432-B1 | PROCESS FOR THE PREPARATION OF IOSIMENOL | MALLINCKRODT LLC (US) | 2012-07-04 | — | — | EP | claimed |
| US-20100280270-A1 | Process for the Prepartion of Iosimenol | MNK 2011 LLC (F/K/A MALLINCKRODT INC.) | 2010-11-04 | — | — | US | claimed |
| EP-2240432-A1 | PROCESS FOR THE PREPARATION OF IOSIMENOL | Mallinckrodt Inc. (US) | 2010-10-20 | — | — | EP | claimed |
| WO-2009091758-A1 | PROCESS FOR THE PREPARATION OF IOSIMENOL | MALLINCKRODT INC. (US) | 2009-07-23 | — | — | WO | claimed |
| US-5623044-A | URETHANE PREPOLYMER AND REACTION PRODUCT OF SECONDARY AMINOALKOXYSILANE AND POLYISOCYANATE; FOR BONDING GLASS TO METALS | ESSEX SPECIALTY PRODUCTS, INC. (US) | 1997-04-22 | — | — | US | claimed |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMA CO LTD (JP) | 2022-02-17 | — | — | US | disclosed |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMA CO LTD (JP) | 2022-02-17 | — | — | US | disclosed |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMA CO LTD (JP) | 2022-02-17 | — | — | US | disclosed |
| US-20200095191-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-03-26 | — | — | US | disclosed |
| US-20200095191-A1 | PROCESS OF PREPARING IOSIMENOL | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-03-26 | — | — | US | disclosed |
| EP-3619192-A1 | PROCESS OF PREPARING IOSIMENOL | Otsuka Pharmaceutical Co., Ltd. (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-3619192-A1 | PROCESS OF PREPARING IOSIMENOL | Otsuka Pharmaceutical Co., Ltd. (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-5851261-A | Process for the production of polyurea encapsulated fertilizer particles and the encapsulated fertilizer particles produced by this process | BAYER CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| US-5698739-A | RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-12-16 | — | — | US | disclosed |
| US-5210246-A | Reacting a tetraalkoxysilicate with aminoalcohol | MITSUBISHI KASEI CORPORATION (JP) | 1993-05-11 | — | — | US | disclosed |
| US-5102924-A | Toughness | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-04-07 | — | — | US | disclosed |
| US-4988549-A | CURABLE POLYISOCYANATE, POLYEPOXIDE REACTION MIXTURE ON POLYAMIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1991-01-29 | — | — | US | disclosed |
| US-4943603-A | POLYURETHANES, POLYUREAS FILLED WITH WOLLASTONITE | THE DOW CHEMICAL COMPANY (US) | 1990-07-24 | — | — | US | disclosed |
| US-4264572-A | TRIIODOISOPHTHALMIC ACID COMPOUNDS FOR MEDICAL DIAGNOSIS | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200095191-A1 | PROCESS OF PREPARING IOSIMENOL | AOC2, SSTR5, SSTR2 | LMNA 2553/4885POLB 1216/4885 |
| US-20100280270-A1 | Process for the Prepartion of Iosimenol | DHCR24, DRD4, NONO | LMNA 713/4885POLB 808/4885 |
| US-20220048852-A1 | PROCESS OF PREPARING IOSIMENOL | AOC2, SSTR2, NISCH | LMNA 3153/4885POLB 1889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.